<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35464749</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1846-7482</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biochemia medica</Title>
          <ISOAbbreviation>Biochem Med (Zagreb)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Laboratory medicine in pandemic of COVID-19.</ArticleTitle>
        <Pagination>
          <StartPage>020501</StartPage>
          <MedlinePgn>020501</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">020501</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.11613/BM.2022.020501</ELocationID>
        <Abstract>
          <AbstractText>After the outbreak in China in the year 2019, severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) quickly spread around the world causing a protracted pandemic. Approximately one-third of infections appear to be asymptomatic. Symptomatic disease is characterized primarily by symptoms of respiratory tract infection of varying severity. But Coronavirus Disease 2019 (COVID-19) is much more than an acute respiratory disease because SARS-CoV-2 affects many organs inducing a vast number of symptoms such as cardiovascular, neurological, gastrointestinal, dermatological, with numerous complications. Short and long-term effects of infection, severe ones, and especially mild forms of the disease which affect a huge number of patients need to be further investigated. Laboratory medicine has a crucial role in early diagnosis of the disease, recognition of the patients who need hospital care, and close monitoring of hospitalized patients to timely identify associated clinical complications as well as follow-up of patients with long-term COVID-19.</AbstractText>
          <CopyrightInformation>Croatian Society of Medical Biochemistry and Laboratory Medicine.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tandara</LastName>
            <ForeName>Leida</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Laboratory Diagnostic, University Hospital Split, Split, Croatia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Split School of Medicine, Split, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Filipi</LastName>
            <ForeName>Petra</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Laboratory Diagnostic, University Hospital Split, Split, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Supe Domic</LastName>
            <ForeName>Daniela</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Laboratory Diagnostic, University Hospital Split, Split, Croatia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University Department of Health Studies, University of Split, Split, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kresic</LastName>
            <ForeName>Branka</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Laboratory Diagnostic, University Hospital Split, Split, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ivcic</LastName>
            <ForeName>Ivo</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>University of Split School of Medicine, Split, Croatia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Clinic for Infectious Diseases, University Hospital Split, Split, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stojanovic Stipic</LastName>
            <ForeName>Sanda</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Split School of Medicine, Split, Croatia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anaesthesiology and Intensive Care, University Hospital Split, Split, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rubic</LastName>
            <ForeName>Zana</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>University of Split School of Medicine, Split, Croatia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Microbiology, University Hospital Split, Split, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tandara</LastName>
            <ForeName>Marijan</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Polyclinic Sparac, Split, Croatia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Biochem Med (Zagreb)</MedlineTA>
        <NlmUniqueID>9610305</NlmUniqueID>
        <ISSNLinking>1330-0962</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007753" MajorTopicYN="N">Laboratories</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">GDF-15</Keyword>
        <Keyword MajorTopicYN="N">Guillain-Barré syndrome</Keyword>
        <Keyword MajorTopicYN="N">infertility</Keyword>
        <Keyword MajorTopicYN="N">interleukin-6</Keyword>
      </KeywordList>
      <CoiStatement>Potential conflict of interest None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
          <Hour>5</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35464749</ArticleId>
        <ArticleId IdType="pmc">PMC8996317</ArticleId>
        <ArticleId IdType="doi">10.11613/BM.2022.020501</ArticleId>
        <ArticleId IdType="pii">bm-32-2-020501</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Dodig S, Čepelak I, Čepelak Dodig D, Laškaj R. SARS-CoV-2 - a new challenge for laboratory medicine.
Biochem Med (Zagreb). 2020;30:030503. 10.11613/BM.2020.030503</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.11613/BM.2020.030503</ArticleId>
            <ArticleId IdType="pmc">PMC7394259</ArticleId>
            <ArticleId IdType="pubmed">32774121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.
Clin Chem Lab Med. 2020;58:1063–9. 10.1515/cclm-2020-0240</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/cclm-2020-0240</ArticleId>
            <ArticleId IdType="pubmed">32191623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin JY, Haiyan Y, Wangquan J, Weidong W, Shuaiyin C, Weiguo Z, et al. 
Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
Viruses. 2020;12:372. 10.3390/v12040372</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v12040372</ArticleId>
            <ArticleId IdType="pmc">PMC7232198</ArticleId>
            <ArticleId IdType="pubmed">32230900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baig AM. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement.
ACS Chem Neurosci. 2020;11:1204–5. 10.1021/acschemneuro.0c00181</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acschemneuro.0c00181</ArticleId>
            <ArticleId IdType="pmc">PMC7192204</ArticleId>
            <ArticleId IdType="pubmed">32343122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McIntosh K. COVID-19: Clinical features. Available from: http://www.uptodate.co. Accessed September 20th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Cuker A, Peywandi F. COVID-19: Hypercoagulability. Available from: http://www.uptodate.com. Accessed September 30th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A, et al. 
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system.
Blood Rev. 2021;46:100745. 10.1016/j.blre.2020.100745</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.blre.2020.100745</ArticleId>
            <ArticleId IdType="pmc">PMC7444609</ArticleId>
            <ArticleId IdType="pubmed">32868115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekholm M, Kahan T. The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19.
Front Pharmacol. 2021;12:640185. 10.3389/fphar.2021.640185</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2021.640185</ArticleId>
            <ArticleId IdType="pmc">PMC8245685</ArticleId>
            <ArticleId IdType="pubmed">34220496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anesi GL. COVID-19: Epidemiology, Clinical features, and prognosis of the critically ill adult. Available from: http://www.uptodate.com. Accessed September 28th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang F, Kream RM, Stefano GB. Long-Term Respiratory and Neurological Sequelae of COVID-19.
Med Sci Monit. 2020;26:e928996. 10.12659/MSM.928996</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/MSM.928996</ArticleId>
            <ArticleId IdType="pmc">PMC7643287</ArticleId>
            <ArticleId IdType="pubmed">33177481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caforio ALP. COVID-19: Cardicac manifestations in adults. Available from: http://www.uptodate.com. Accessed September 30th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Bansal M. Cardiovascular disease and COVID-19.
Diabetes Metab Syndr. 2020;14:247–50. 10.1016/j.dsx.2020.03.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.dsx.2020.03.013</ArticleId>
            <ArticleId IdType="pmc">PMC7102662</ArticleId>
            <ArticleId IdType="pubmed">32247212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>AlShahrani I, Hosmani J, Shankar VG, AlShahrani A, Togoo RA, Yassin SM, et al. 
COVID-19 and cardiovascular system-a comprehensive review.
Rev Cardiovasc Med. 2021;22:343–51. 10.31083/j.rcm2202041</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.31083/j.rcm2202041</ArticleId>
            <ArticleId IdType="pubmed">34258902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkind MSV, Cucchiara BL, Koralnik I. COVID-19: Neurologic complications and magement of neruologic conditions. Available from: http://www.uptodate.com. Accessed September 28th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Neurol Sci. 2020;41:2657–69. 10.1007/s10072-020-04575-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-020-04575-3</ArticleId>
            <ArticleId IdType="pmc">PMC7385206</ArticleId>
            <ArticleId IdType="pubmed">32725449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, et al. 
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
J Neurol Sci. 2020;417:117085. 10.1016/j.jns.2020.117085</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2020.117085</ArticleId>
            <ArticleId IdType="pmc">PMC7413162</ArticleId>
            <ArticleId IdType="pubmed">32871412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Son MBF, Friedman K. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, aevaluation, and diganosis. Available from: http://www.uptodate.com. Accessed September 30th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
Children (Basel). 2020;7:69. 10.3390/children7070069</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/children7070069</ArticleId>
            <ArticleId IdType="pmc">PMC7401880</ArticleId>
            <ArticleId IdType="pubmed">32630212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children.
Nat Rev Immunol. 2020;20:453–4. 10.1038/s41577-020-0367-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41577-020-0367-5</ArticleId>
            <ArticleId IdType="pmc">PMC7296515</ArticleId>
            <ArticleId IdType="pubmed">32546853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mikkelsen ME, Abramoff B. COVID-19: Evaluation and management following acute viral illness. Available from: http://www.uptodate.com. Accessed September 28th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Steardo L Jr, Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Transl Psychiatry. 2020;10:261. 10.1038/s41398-020-00949-5. https://doi.org/10.1038/s41398-020-00949-510.1038/s41398-020-00949-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41398-020-00949-5</ArticleId>
            <ArticleId IdType="doi">10.1038/s41398-020-00949-5</ArticleId>
            <ArticleId IdType="doi">10.1038/s41398-020-00949-5</ArticleId>
            <ArticleId IdType="pmc">PMC7391235</ArticleId>
            <ArticleId IdType="pubmed">32732883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ISO 22870:2016. Point-of-care testing (POCT) – Requirements for quality and competence. Available from: https://www.iso.org/standard/71119.html. Accessed October 17th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results.
Expert Rev Mol Diagn. 2020;20:453–4. 10.1080/14737159.2020.1757437</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14737159.2020.1757437</ArticleId>
            <ArticleId IdType="pmc">PMC7189409</ArticleId>
            <ArticleId IdType="pubmed">32297805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Guidance for SARS-CoV-2 Point-of-Care and Rapid Testing. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html. Accessed October 17th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>European Centre for Disease Prevention and Control. Considerations for the use of saliva as sample material for COVID-19 testing. Available from: https://www.ecdc.europa.eu/en/publications-data/considerations-use-saliva-sample-material-covid-19-testing. Accessed January 17th 2022.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. COVID-19 Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0. Available from: https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1. Accessed October 15th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>van Kampen JJA, van de Vijver DAMC, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, et al. 
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).
Nat Commun. 2021;12:267. 10.1038/s41467-020-20568-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-020-20568-4</ArticleId>
            <ArticleId IdType="pmc">PMC7801729</ArticleId>
            <ArticleId IdType="pubmed">33431879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinnes J, Deeks JJ, Berhane S, Taylor M, Adriano A, Davenport C, et al. 
Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection.
Cochrane Database Syst Rev. 2021;3:CD013705. 10.1002/14651858.CD013705.pub2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD013705.pub2</ArticleId>
            <ArticleId IdType="pmc">PMC8078597</ArticleId>
            <ArticleId IdType="pubmed">33760236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palladino M. Complete blood count alterations in COVID-19 patients.
Biochem Med (Zagreb). 2021;31:030501. 10.11613/BM.2021.030501</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.11613/BM.2021.030501</ArticleId>
            <ArticleId IdType="pmc">PMC8495616</ArticleId>
            <ArticleId IdType="pubmed">34658642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh A, Sood N, Narang V, Goyal A. Morphology of COVID-19-affected cells in peripheral blood film.
BMJ Case Rep. 2020;13:e236117. 10.1136/bcr-2020-236117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2020-236117</ArticleId>
            <ArticleId IdType="pmc">PMC7276239</ArticleId>
            <ArticleId IdType="pubmed">32467125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pezeshki A, Vaezi A, Nematollahi P. Blood cell morphology and COVID-19 clinical course, severity, and outcome.
J Hematop. 2021;14:221–8. 10.1007/s12308-021-00459-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12308-021-00459-3</ArticleId>
            <ArticleId IdType="pmc">PMC8255335</ArticleId>
            <ArticleId IdType="pubmed">34249171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu YP, Liu Y, Huang QC, Chen M, Diao B. Morphological changes of lymphocytes in peripheral blood smears of patients with COVID-19.
Ann Palliat Med. 2020;9:4420–2. 10.21037/apm-20-558</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/apm-20-558</ArticleId>
            <ArticleId IdType="pubmed">33183023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gérard D, Henry S, Thomas B. SARS-CoV-2: a new aetiology for atypical lymphocytes.
Br J Haematol. 2020;189:845. 10.1111/bjh.16730</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjh.16730</ArticleId>
            <ArticleId IdType="pmc">PMC7264674</ArticleId>
            <ArticleId IdType="pubmed">32311762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salib C, Khattar P, Cheng J, Teruya-Feldstein J. Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City.
Blood. 2020;136:26–7. 10.1182/blood-2020-142581</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2020-142581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kannan G, Soni M. Leukocyte morphological changes in COVID-19, a peripheral smear study and analysis at a tertiary health care centre in India.
Apollo Med.
2021;18:158–61.</Citation>
        </Reference>
        <Reference>
          <Citation>Zini G, Bellesi S, Ramundo F, d’Onofrio G. Morphological anomalies of circulating blood cells in COVID-19.
Am J Hematol. 2020;95:870–2. 10.1002/ajh.25824</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajh.25824</ArticleId>
            <ArticleId IdType="pmc">PMC7262044</ArticleId>
            <ArticleId IdType="pubmed">32279346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sadigh S, Massoth LR, Christensen BB, Stefely JA, Keefe J, Sohani AR. Peripheral blood morphologic findings in patients with COVID-19.
Int J Lab Hematol. 2020;42:e248–51. 10.1111/ijlh.13300</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijlh.13300</ArticleId>
            <ArticleId IdType="pubmed">32730694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berber I, Cagasar O, Sarici A, Berber NK, Aydogdu I, Yildirim A, et al. 
Simple Peripheral Blood Smear Findings of COVID-19 Patients Provide İnformation about the Severity of the Disease and the Duration of Hospital Stay.
Mediterr J Hematol Infect Dis. 2020;13:e2021009. 10.4084/mjhid.2021.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4084/mjhid.2021.009</ArticleId>
            <ArticleId IdType="pmc">PMC7813282</ArticleId>
            <ArticleId IdType="pubmed">33489048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nazarullah A, Liang C, Villarreal A, Higgins RA, Mais DD. Peripheral Blood Examination Findings in SARS-CoV-2 Infection.
Am J Clin Pathol. 2020;154:319–29. 10.1093/ajcp/aqaa108</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ajcp/aqaa108</ArticleId>
            <ArticleId IdType="pmc">PMC7454310</ArticleId>
            <ArticleId IdType="pubmed">32756872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pozdnyakova O, Connell NT, Battinelli EM, Connors JM, Fell G, Kim AS. Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection.
Am J Clin Pathol. 2021;155:364–75. 10.1093/ajcp/aqaa231</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ajcp/aqaa231</ArticleId>
            <ArticleId IdType="pmc">PMC7799218</ArticleId>
            <ArticleId IdType="pubmed">33269374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olcay L, Yegin S. Disorders mimicking myelodysplastic syndrome and difficulties in its diagnosis. In: Fuchs O, ed. Myelodysplastic Syndromes. London: IntechOpen. 2016. p.45-94. 10.5772/6442210.5772/64422</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5772/64422</ArticleId>
            <ArticleId IdType="doi">10.5772/64422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hennigar SR, McClung JP. Nutritional Immunity: Starving Pathogens of Trace Minerals.
Am J Lifestyle Med. 2016;10:170–3. 10.1177/1559827616629117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1559827616629117</ArticleId>
            <ArticleId IdType="pmc">PMC6124953</ArticleId>
            <ArticleId IdType="pubmed">30202269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vyoral D, Petrák J. Hepcidin: a direct link between iron metabolism and immunity.
Int J Biochem Cell Biol. 2005;37:1768–73. 10.1016/j.biocel.2005.02.023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2005.02.023</ArticleId>
            <ArticleId IdType="pubmed">16009323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt SM. The role of iron in viral infections.
Front Biosci (Landmark Ed). 2020;25:893–911. 10.2741/4839</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2741/4839</ArticleId>
            <ArticleId IdType="pubmed">31585922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armitage AE, Stacey AR, Giannoulatou E, Marshall E, Sturges P, Chatha K, et al. 
Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections.
Proc Natl Acad Sci USA. 2014;111:12187–92. 10.1073/pnas.1402351111</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1402351111</ArticleId>
            <ArticleId IdType="pmc">PMC4142992</ArticleId>
            <ArticleId IdType="pubmed">25092293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banchini F, Vallisa D, Maniscalco P, Capelli P. Iron overload and Hepcidin overexpression could play a key role in COVID infection, and may explain vulnerability in elderly, diabetics, and obese patients.
Acta Biomed. 2020;91:e2020013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7716981</ArticleId>
            <ArticleId IdType="pubmed">32921750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edeas M, Saleh J, Peyssonnaux C. Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
Int J Infect Dis. 2020;97:303–5. 10.1016/j.ijid.2020.05.110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijid.2020.05.110</ArticleId>
            <ArticleId IdType="pmc">PMC7264936</ArticleId>
            <ArticleId IdType="pubmed">32497811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang M, Lai CL. SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement?
Cell Death Discov. 2020;6:130. 10.1038/s41420-020-00369-w</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41420-020-00369-w</ArticleId>
            <ArticleId IdType="pmc">PMC7687212</ArticleId>
            <ArticleId IdType="pubmed">33251029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tandara L, Salamunic I. Iron metabolism: current facts and future directions.
Biochem Med (Zagreb). 2012;22:311–28. 10.11613/BM.2012.034</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.11613/BM.2012.034</ArticleId>
            <ArticleId IdType="pmc">PMC3900049</ArticleId>
            <ArticleId IdType="pubmed">23092063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou C, Chen Y, Ji Y, He X, Xue D. Increased serum levels of hepcidin and ferritin are associated with severity of COVID-19.
Med Sci Monit. 2020;26:e926178. 10.12659/MSM.926178</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/MSM.926178</ArticleId>
            <ArticleId IdType="pmc">PMC7526336</ArticleId>
            <ArticleId IdType="pubmed">32978363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nai A, Lorè NI, Pagani A, De Lorenzo R, Di Modica S, Saliu F, et al. 
Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients.
Am J Hematol. 2021;96:E32–5. 10.1002/ajh.26027</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajh.26027</ArticleId>
            <ArticleId IdType="pubmed">33075189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yağcı S, Serin E, Acicbe Ö, Zeren Mİ, Odabaşı MS. The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19.
Int J Lab Hematol. 2021;43:142–51. 10.1111/ijlh.13479</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijlh.13479</ArticleId>
            <ArticleId IdType="pmc">PMC8014125</ArticleId>
            <ArticleId IdType="pubmed">33554466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellmann-Weiler R, Lanser L, Barket R, Rangger L, Schapfl A, Schaber M, et al. 
Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection.
J Clin Med. 2020;9:2429–39. 10.3390/jcm9082429</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9082429</ArticleId>
            <ArticleId IdType="pmc">PMC7464087</ArticleId>
            <ArticleId IdType="pubmed">32751400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah A, Frost JN, Aaron L, Donovan K, Drakesmith H, McKechnie SR, et al. . Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19.
Crit Care. 2020;24:320. 10.1186/s13054-020-03051-w</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13054-020-03051-w</ArticleId>
            <ArticleId IdType="pmc">PMC7280775</ArticleId>
            <ArticleId IdType="pubmed">32517773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kappert K, Jahić A, Tauber R. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases.
Biomarkers. 2020;25:616–25. 10.1080/1354750X.2020.1797880</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/1354750X.2020.1797880</ArticleId>
            <ArticleId IdType="pubmed">32700561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed S, Ansar Ahmed Z, Siddiqui I, Haroon Rashid N, Mansoor M, Sibtain Ahmed JL, et al. . Evaluation of serum ferritin for prediction of severity and mortality in COVID-19- A cross sectional study.
Ann Med Surg (Lond). 2021;63:102163. 10.1016/j.amsu.2021.02.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amsu.2021.02.009</ArticleId>
            <ArticleId IdType="pmc">PMC7879065</ArticleId>
            <ArticleId IdType="pubmed">33614024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosário C, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome.
BMC Med. 2013;11:185. 10.1186/1741-7015-11-185</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1741-7015-11-185</ArticleId>
            <ArticleId IdType="pmc">PMC3751883</ArticleId>
            <ArticleId IdType="pubmed">23968282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gómez-Pastora J, Weigand M, Kim J, Wu X, Strayer J, Palmer AF, et al. 
Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator?
Clin Chim Acta. 2020;509:249–51. 10.1016/j.cca.2020.06.033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cca.2020.06.033</ArticleId>
            <ArticleId IdType="pmc">PMC7306200</ArticleId>
            <ArticleId IdType="pubmed">32579952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Čepelak I, Dodig S, Vučenik I. Hyperferritinemia and COVID-19? RAD CASA -. Med Sci. 2020;544:18–25. 10.21857/ygjwrcdv0y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21857/ygjwrcdv0y</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ehsani S. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein.
Biol Direct. 2020;15:19. 10.1186/s13062-020-00275-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13062-020-00275-2</ArticleId>
            <ArticleId IdType="pmc">PMC7563913</ArticleId>
            <ArticleId IdType="pubmed">33066821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonnweber T, Boehm A, Sahanic S, Pizzini A, Aichner M, Sonnweber B, et al. 
Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study.
Respir Res. 2020;21:276. 10.1186/s12931-020-01546-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12931-020-01546-2</ArticleId>
            <ArticleId IdType="pmc">PMC7575703</ArticleId>
            <ArticleId IdType="pubmed">33087116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Čulo F. [Citokini i kemokini]. In: Andreis I, Batinic D, eds. [Imunologija]. Zagreb: Medicinska naklada; 2010. p.123-132. (In Croatian)</Citation>
        </Reference>
        <Reference>
          <Citation>Vatansever HS, Becer E, Vatansever HS, Becer E. Relationship between IL-6 and COVID 19: to be considered during treatment.
Future Virol. 2020;15:817–22. 10.2217/fvl-2020-0168</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/fvl-2020-0168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, et al. 
Interleukin-6 as prognosticator in patients with COVID-19.
J Infect. 2020;81:452–82. 10.1016/j.jinf.2020.06.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2020.06.008</ArticleId>
            <ArticleId IdType="pmc">PMC7278637</ArticleId>
            <ArticleId IdType="pubmed">32526326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Clin Rheumatol. 2020;39:2085–94. 10.1007/s10067-020-05190-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-020-05190-5</ArticleId>
            <ArticleId IdType="pmc">PMC7260446</ArticleId>
            <ArticleId IdType="pubmed">32474885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen LYC, Hoiland RL, Stukas S, Wellington CL, Sekhon MS. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome.
Eur Respir J. 2020;56:2003006. 10.1183/13993003.03006-2020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.03006-2020</ArticleId>
            <ArticleId IdType="pmc">PMC7474149</ArticleId>
            <ArticleId IdType="pubmed">32883678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, et al. 
The looming storm: blood and cytokines in COVID-19.
Blood Rev. 2021;46:100743. 10.1016/j.blre.2020.100743</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.blre.2020.100743</ArticleId>
            <ArticleId IdType="pmc">PMC7431319</ArticleId>
            <ArticleId IdType="pubmed">32829962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galván-Román JM, Rodriguez-Garcia S. IL-6 serum levels predict severity and response to tocilizumab in COVID-19: an obsevational study.
J Allergy Clin Immunol. 2021;147:72–80..e8 10.1016/j.jaci.2020.09.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2020.09.018</ArticleId>
            <ArticleId IdType="pmc">PMC7525244</ArticleId>
            <ArticleId IdType="pubmed">33010257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donoso-Navarro E, Arribas Gómez I, Bernabeu-Andreu FA. IL-6 and other biomarkers associated with poor prognosis in a cohort of hospitalized patients with COVID-19 in Madrid.
Biomark Insights. 2021;16:11772719211013363. 10.1177/11772719211013363</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/11772719211013363</ArticleId>
            <ArticleId IdType="pmc">PMC8150444</ArticleId>
            <ArticleId IdType="pubmed">34103886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen X, Zhou J, Chen C, Hou B, Ali A, Li F, et al. 
Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients.
Virol Sin. 2021;36:1093–6. 10.1007/s12250-021-00425-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12250-021-00425-4</ArticleId>
            <ArticleId IdType="pmc">PMC8261036</ArticleId>
            <ArticleId IdType="pubmed">34232450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sabaka P, Koščalova A, Straka J, Hodosy J, Liptak R, Kmotorkova B, et al. 
Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak.
BMC Infect Dis. 2021;21:308. 10.1186/s12879-021-05945-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-021-05945-8</ArticleId>
            <ArticleId IdType="pmc">PMC8006112</ArticleId>
            <ArticleId IdType="pubmed">33781216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santa Cruz A, Mendes-Frias A, Oliveira AI, Dias L, Matos AR, Carvalho A, et al. 
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.
Front Immunol. 2021;12:613422. 10.3389/fimmu.2021.613422</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2021.613422</ArticleId>
            <ArticleId IdType="pmc">PMC7930905</ArticleId>
            <ArticleId IdType="pubmed">33679753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gorham J, Moreau A, Corazza F, Peluso L, Ponthieux F, Talamonti M, et al. 
Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.
PLoS One. 2020;15:e0244628. 10.1371/journal.pone.0244628</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0244628</ArticleId>
            <ArticleId IdType="pmc">PMC7774924</ArticleId>
            <ArticleId IdType="pubmed">33382773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu XF, Zhan R, Xu S, Wang J, Wu J, Liu X, et al. 
Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
Clin Cardiol. 2018;41:34–8. 10.1002/clc.22844</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/clc.22844</ArticleId>
            <ArticleId IdType="pmc">PMC6489975</ArticleId>
            <ArticleId IdType="pubmed">29363835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, Rabaan AA, Sah R, Paniz-Mondolfi A, et al. 
History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic.
Infez Med. 2020;28:3–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32009128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilson J, Scorletti E, Bindels LB, Afolabi PR, Targher G, Calder PC, et al. 
Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD.
Nutr Diabetes. 2021;11:32. 10.1038/s41387-021-00170-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41387-021-00170-3</ArticleId>
            <ArticleId IdType="pmc">PMC8523689</ArticleId>
            <ArticleId IdType="pubmed">34663793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akbari H, Talaee R, Zaker SF, Nikoueinejad H. Investigating the Correlation between Growth Differentiation Factor 15 Serum Level and Its Gene Expression with Psoriasis and Its Severity.
Iran J Allergy Asthma Immunol. 2021;20:593–9. 10.18502/ijaai.v20i5.7409</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18502/ijaai.v20i5.7409</ArticleId>
            <ArticleId IdType="pubmed">34664818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wollert KC. Growth-differentiation factor-15 in cardiovascular disease.
Basic Res Cardiol. 2007;102:412–5. 10.1007/s00395-007-0662-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00395-007-0662-3</ArticleId>
            <ArticleId IdType="pubmed">17546529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teng X, Zhang J, Shi Y, Liu Y, Yang Y, He J, et al. 
Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients.
Front Immunol. 2021;12:662465. 10.3389/fimmu.2021.662465</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2021.662465</ArticleId>
            <ArticleId IdType="pmc">PMC8320433</ArticleId>
            <ArticleId IdType="pubmed">34335566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myhre PL, Prebensen C, Strand H, Røysland R, Jonassen CM, Rangberg A, et al. 
Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID.
Circulation. 2020;142:2128–37. 10.1161/CIRCULATIONAHA.120.050360</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050360</ArticleId>
            <ArticleId IdType="pmc">PMC7688084</ArticleId>
            <ArticleId IdType="pubmed">33058695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazagova M, Buikema H, Landheer SW, Vavrinec P, van Buiten A, Henning RH, et al. 
Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium.
Am J Physiol Heart Circ Physiol. 2013;304:H709–18. 10.1152/ajpheart.00543.2012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00543.2012</ArticleId>
            <ArticleId IdType="pubmed">23262134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long Covid: what is it, and what is needed? London: Royal Society; Available from: https://royalsociety.org/-/media/policy/projects/set-c/set-c-long-covid.pdf. Accessed October 23rd 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Diaz JV, Soriano JB. A Delphi consensus to advance on a clinical case definition for post COVID-19 condition: a WHO protocol. Protocol Exchange. 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed October 30th 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Smith S, Rahman O. Post Intensive Care Syndrome. StatPearls [Internet]. 2021 July [cited 2021 Oct 15] Available from: https://www.ncbi.nlm.nih.gov/books/NBK558964/.</Citation>
        </Reference>
        <Reference>
          <Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. 
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.
EClinicalMedicine. 2021;38:101019. 10.1016/j.eclinm.2021.101019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId>
            <ArticleId IdType="pmc">PMC8280690</ArticleId>
            <ArticleId IdType="pubmed">34308300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soriano JB, Waterer G, Peñalvo JL, Rello J. Nefer, Sinuhe and clinical research assessing post COVID-19 condition.
Eur Respir J. 2021;57:2004423. 10.1183/13993003.04423-2020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.04423-2020</ArticleId>
            <ArticleId IdType="pmc">PMC7778876</ArticleId>
            <ArticleId IdType="pubmed">33380509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. 
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury.
Nat Med. 2005;11:875–9. 10.1038/nm1267</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1267</ArticleId>
            <ArticleId IdType="pmc">PMC7095783</ArticleId>
            <ArticleId IdType="pubmed">16007097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan PP, Zhan QT, Le F, Zheng YM, Jin F. Angiotensin-converting enzymes play a dominant role in fertility.
Int J Mol Sci. 2013;14:21071–86. 10.3390/ijms141021071</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms141021071</ArticleId>
            <ArticleId IdType="pmc">PMC3821659</ArticleId>
            <ArticleId IdType="pubmed">24152441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herr D, Bekes I, Wulff C. Local renin-angiotensin system in the reproductive system.
Front Endocrinol (Lausanne). 2013;4:150. 10.3389/fendo.2013.00150</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2013.00150</ArticleId>
            <ArticleId IdType="pmc">PMC3798827</ArticleId>
            <ArticleId IdType="pubmed">24151488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu M, Ma L, Xue L, Zhu Q, Zhou S, Dai J, et al. 
Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age.
Genomics. 2021;113:3449–60. 10.1016/j.ygeno.2021.08.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ygeno.2021.08.012</ArticleId>
            <ArticleId IdType="pmc">PMC8372464</ArticleId>
            <ArticleId IdType="pubmed">34418496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vannuccini S, Clifton VL, Fraser IS, Taylor HS, Critchley H, Giudice LC, et al. 
Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome.
Hum Reprod Update. 2016;22:104–15. 10.1093/humupd/dmv044</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humupd/dmv044</ArticleId>
            <ArticleId IdType="pmc">PMC7289323</ArticleId>
            <ArticleId IdType="pubmed">26395640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cavallo IK, Dela Cruz C, Oliveira ML, Del Puerto HL, Dias JA, Lobach VN, et al. 
Angiotensin-(1-7) in human follicular fluid correlates with oocyte maturation.
Hum Reprod. 2017;32:1318–24. 10.1093/humrep/dex072</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/dex072</ArticleId>
            <ArticleId IdType="pubmed">28402544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vinson GP, Saridogan E, Puddefoot JR, Djahanbakhch O. Tissue renin-angiotensin systems and reproduction.
Hum Reprod. 1997;12:651–62. 10.1093/humrep/12.4.651</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/12.4.651</ArticleId>
            <ArticleId IdType="pubmed">9159419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang M, Yang Q, Ren X, Hu J, Li Z, Long R, et al. 
Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and in vitro fertilization outcomes: A retrospective cohort study.
EClinicalMedicine. 2021;38:101013. 10.1016/j.eclinm.2021.101013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eclinm.2021.101013</ArticleId>
            <ArticleId IdType="pmc">PMC8259363</ArticleId>
            <ArticleId IdType="pubmed">34250457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang C, Ji X, Zhou W, Huang Z, Peng X, Fan L, et al. 
Coronavirus: a possible cause of reduced male fertility.
Andrology. 2021;9:80–7. 10.1111/andr.12907</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/andr.12907</ArticleId>
            <ArticleId IdType="pmc">PMC7537192</ArticleId>
            <ArticleId IdType="pubmed">32960504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Younis JS, Abassi Z, Skorecki K. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.
Am J Physiol Endocrinol Metab. 2020;318:E878–80. 10.1152/ajpendo.00183.2020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00183.2020</ArticleId>
            <ArticleId IdType="pmc">PMC7276979</ArticleId>
            <ArticleId IdType="pubmed">32421367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee WY, Mok A, Chung JPW. Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: a review.
Hong Kong Med J. 2021;27:118–26. 10.12809/hkmj209078</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12809/hkmj209078</ArticleId>
            <ArticleId IdType="pubmed">33853972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haghpanah A, Masjedi F, Alborzi S, Hosseinpour A, Dehghani A, Malekmakan L, et al. 
Potential mechanisms of SARS-CoV-2 action on male gonadal function and fertility: Current status and future prospects.
Andrologia. 2021;53:e13883. 10.1111/and.13883</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/and.13883</ArticleId>
            <ArticleId IdType="pmc">PMC7645932</ArticleId>
            <ArticleId IdType="pubmed">33108833</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
